Mission Statement

The Division of Pharmacognosy carries out research in pharmaceutical sciences focused on natural products from medicinal plants and microorganisms. Major tasks are the discovery of new biologically active compounds from natural sources and the characterization of their molecular mode of action contributing to a better understanding of the interaction of natural products and complex cellular systems. Our aim is pharmaceutical lead and target identification, the quality improvement of herbal medicinal products as well as the sustainable production of natural products by biotechnological approaches.

12.01.2019
 

A new antibiotic, named viennamycin, was isolated from a soil-dwelling bacterium of the genus Streptomyces in the Pharmaceutical biotechnology group (head Sergey B. Zotchev). This work is supported by Austria Wirtschaftsservice Gesellschaft mbH, project P1715748-WZP01 “Viennamycin Antibiotika”.

11.01.2019
 

... has been awarded to the Pharmaceutical biotechnology group (Sergey B. Zotchev). The project aims at deciphering molecular mechanism of antibiotic biosynthesis stimulation in Streptomyces bacterium in response to environmental stress. Cooperating partners are Thomas Rattei (Department of Microbiology and Ecosystem Science) and Martin Zehl (Mass Spectrometry Centre).

10.01.2019
 

“Anti-inflammatory aspects of neolignans from Magnolia officinalis” by Angela Ladurner. The granted project by the Hochschuljubiläumsstiftung der Stadt Wien aims to elucidate the underlying mechanism behind anti-inflammatory neolignans from Magnolia officinalis.

18.12.2018
 

Ramin Nikzad-Langerodi successfully passed his defensio entitled “Quality Control of Herbal Medicines by Attenuated Total Reflectance Fourier-Transform Infrared Spectroscopy” on December 17, 2018. Supervisor: Johannes Saukel.

14.12.2018
 

“Self medication in Darwin’s finches: identifying the mosquito repellent components of Psidium galapageum” by S. Tebbich (Dept. of Behavioural Biology) and L. Krenn (Dept. of Pharmacognosy).

11.12.2018
 

The NATVANTAGE project granted by the Wilhelm Doerenkamp foundation is dedicated to the development of new therapeutic agents from nature. This year they granted the NaProFlu Project (Judith M. Rollinger), in which the newly appointed doctoral student, Julia Langeder (foto), is researching on the development of a multipotent anti-influenza herbal agent.